Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-25T05:54:50.347Z Has data issue: false hasContentIssue false

Magnetic Resonance Imaging:Overview of the Technology and Medical Applications

Published online by Cambridge University Press:  10 March 2009

Lisa I. lezzoni
Affiliation:
Boston University Medical Center
Oren Grad
Affiliation:
Massachusetts Institute of Technology
Mark A. Moskowitz
Affiliation:
Boston Unverisity Medical Center

Extract

The physical phenomenon of nuclear magnetic resonance (NMR) was first characterized almost forty years ago in 1946 by the simultaneous but independent experimental successes of American scientists Felix Bloch and Edward Purcell. Their discoveries prompted development of conventional NMR spectroscopy. a technique used to describe the molecular composition and behavior of chemical compounds. Twenty-five years later, in 1971, Damadian used NMR to demonstrate differences in the behavior of water in malignant and benign tissues, and he suggested that NMR possessed “many of the desirable features of an external probe for the detection of internal cancer” (7). In the same year, Lauterbur produced the first two-dimensional NMR image, a cross-sectional portrait of two tubes of water (25). The potential utility of this technique to medical imaging was obvious, and soon afterwards multiple researchers began development of clinical NMR imaging systems. The first human whole-body NMR scan was accomplished by 1977. Improvements in the scanning process and image quality continue with, as yet, no limits in sight. In this clinical context, NMR techniques have experienced a name change to the current prevailing appellation, magnetic resonance imaging (MRI).

Type
An International View of Magnetic Resonance—Imaging and Spectroscopy
Copyright
Copyright © Cambridge University Press 1985

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Allman, R. M., Steinberg, E. P., Keruly, J. C., & Dans, P. E.Physician tolerance for uncertainty: Use of liver-spleen scan to detect metastases. Journal of the American Medical Association, 1985, 254, 246–48.CrossRefGoogle ScholarPubMed
2.American Hospital Association. NMR—issues for 1985 and beyond. Chicago, IL: AHA Hospital Technology Series, 1985.Google Scholar
3.Baker, H. L., Berquist, T. H., Kispert, D. B. et al. , Magnetic resonance imaging in a routine clinical setting. Mayo Clinic Proceedings, 1985, 60, 7590.Google Scholar
4.Bradley, W. G.Magnetic resonance imaging of the central nervous system. Neurological Research, 1984, 6, 91106.CrossRefGoogle ScholarPubMed
5.Brant-Zawadzki, M., Norman, D., Newton, T. H. et al. , Magnetic resonance of the brain: The optimal screening technique. Radiology, 1984, 152, 7177.CrossRefGoogle ScholarPubMed
6.Budinger, T. F., & Lauterbur, P. C.Nuclear magnetic resonance technology for medical studies. Science, 1984, 226, 288–98.Google Scholar
7.Damadian, R.Tumor detection by nuclear magnetic resonance. Science, 1971, 171, 1151–53.CrossRefGoogle ScholarPubMed
8.DiChiro, G.Magnetic resonance imaging: A time for assessment. Mayo Clinic Proceedings, 1985, 60, 135–36.CrossRefGoogle Scholar
9.Edelman, R. R., Shoukimas, G. M., Stark, D. D. et al. , High-resolution surface-coilimaging of lumbar disk disease. American Journal of Roentgenology, 1985, 144, 1123–29.Google Scholar
10.Elscint, Ltd. Magnets in magnetic resonance imaging. Haifa, Israel: Elscint, Ltd., 1983.Google Scholar
11.Emmerson, B. T. Toxic nephropathy. In Wyngaarden, J. B. & Smith, L. H. (eds.), Cecil textbook of medicine. Philadelphia, PA: W. B. Saunders, 1982.Google Scholar
12.Federation of American Hospitals Review. NMR, the technology of the future, is watched closely by the industry now. Federation of American Hospitals Review, 1983, 16, 2228.Google Scholar
13.Fineberg, H. V., Dean, Harvard School of Public Health, Boston, MA. Personal communication, June 10, 1985.Google Scholar
14.Gadian, D. G., Payne, J. A., Bryant, D. J. et al. , Gadolinium-DTPA as a contrast agent in MR imaging-theoretical projections and practical observations. Journal of Computer Assisted Tomography, 1985, 9, 242–51.Google Scholar
15.Goldman, S. G., Elscint, Inc., Boston, MA. Personal communication, June 6, 1985.Google Scholar
16.Han, J. S., Bonstelle, C. T., Kaufman, B. et al. , Magnetic resonance imaging in the evaluation of the brainstem. Radiology, 1984, 150, 705–12.Google Scholar
17.Hendee, W. R., & Morgan, C. J.Magnetic resonance imaging part II—clinical applications. Western Journal of Medicine, 1984, 141, 638–48.Google Scholar
18.Higgins, C. B., Hricak, H., Gamsu, G. et al. , Clinical nuclear magnetic resonance imaging of the body. Seminars in Nuclear Medicine, 1983, 13, 347–63.Google Scholar
19.Higgins, C. B., Kaufman, L., & Crooks, L. E.Magnetic resonance imaging of the cardiovascular system. American Heart Journal, 1985, 109, 136–52.CrossRefGoogle ScholarPubMed
20.Hilal, S. K., Maudsley, A. A., Ra, J. B. et al. , In vivo imaging of sodium-23 in the human head. Journal of Computer Assisted Tomography, 1985, 9, 17.CrossRefGoogle ScholarPubMed
21.Holgate, R. C., & Wortzman, G.The medical and financial impact of computed to mography scanning: effects of inertia. Journal Beige de Radiologie, 1978, 61, 427–37.Google Scholar
22.Kjos, B. O., Ehman, R. L., & Brant-Zawadzki, M.Reproducibility of Tl and T2 relaxation times calculated from routine MR imaging sequences: Phantom study. American Journal of Roentgenology, 1985, 144, 1157–63.Google Scholar
23.Kjos, B. O., Ehman, R. L., Brant-Zawadzki, M. et al. , Reproducibility of relaxation times and spin density calculated from routine MR imaging sequences: Clinical study of the CNS. American Journal of Roentgenology, 1985, 144, 1165–70.Google Scholar
24.Kneeland, J. B., Lee, B. C. P., Whalen, J. P. et al. , NMR: The new frontier in diagnostic radiology. Advances in Surgery, 1984, 18, 3750.Google ScholarPubMed
25.Lauterbur, P. C.Image formation by induced local interactions: Examples employing nuclear magnetic resonance. Nature, 1973, 242, 190–91.Google Scholar
26.McFarland, E., Koutcher, J. A., Rosen, B. R. et al. , In vivo 19F NMR imaging. Journal of Computer Assisted Tomography, 1985, 9, 815.CrossRefGoogle Scholar
27.Mechlin, M., Thickman, D., Kressel, H. Y. et al. , Magnetic resonance imaging of postoperative patients with metallic implants. American Journal of Roentgenology, 1984, 143, 1281–84.CrossRefGoogle ScholarPubMed
28.Medical Letter. Magnetic resonance imaging. Medical Letter, 1985, 27, 4344.Google Scholar
29.Modic, M. T., Pavlicek, W., Weinstein, M. A. et al. , Magnetic resonance imaging of intervertebral disc disease. Radiology, 1984, 152, 103111.Google Scholar
30.Mohr, J. P., Kase, C. S., & Adams, R. D. Cerebrovascular diseases. In Petersdorf, R. G., Adams, R. D., Braunwald, E. et al. , (eds.), Harrison's principles of internal medicine. New York: McGraw-Hill, 1983.Google Scholar
31.Murphy, W. A.How does magnetic resonance compare with computed tomography? Radiology, 1984, 152, 235–36.Google Scholar
32.Parrot, T., Philips Medical Systems, Inc., Shelton, CT. Personal communication, June 5, 1985.Google Scholar
33.Paushter, D. W., Modic, M. T., Borkowski, G. P. et al. , Magnetic resonance principles and applications. Medical Clinics of North America, 1984, 68, 13931421.CrossRefGoogle Scholar
34.Posin, J. P., Ortendahl, D. A., Hylton, N. M. et al. , Variable magnetic resonance imaging parameters: Effect on detection and characterization of lesions. Radiology, 1985, 155, 719–25.Google Scholar
35.Radda, G. K.High-resolution phosphorus-31 nuclear magnetic resonance in clinical medicine. In E. M. Bradbury (moderator), Nuclear magnetic resonance techniques in medicine. Annals of Internal Medicine, 1983, 98, 514–29.Google Scholar
36.Schenk, J. F., Hart, H. R., Foster, T. H. et al. , Improved MR imaging of the orbit at 1.5T with surface coils. American Journal of Roentgenology, 1985, 144, 1033–36.Google Scholar
37.Schroeder, S. A.Magnetic resonance imaging: Present costs and potential gains. Annals of Internal Medicine, 1985, 102, 551–53.CrossRefGoogle ScholarPubMed
38.Schwartz, J. S., & Hillman, A. L.The adoption and diffusion of equipment embodied technology in the DRG era: the case of magnetic resonance imaging. Unpublished paper. Hospital of the University of Pennsylvania, 1985.Google Scholar
39.Singer, J. R., & Crooks, L. E.Nuclear magnetic resonance blood flow measurements in the human brain. Science, 1983, 221, 654–56.Google Scholar
40.Smith, F. W.Two years' clinical experience with NMR imaging. Applied Radiology, 1983, 2942.Google Scholar
41.Stason, W. B., & Localio, A. R.Magnetic resonance imaging: Clinical efficacy, costs, and policy considerations. Chicago, IL: Blue Cross and Blue Shield Association, 1985.Google Scholar
42.Steinberg, E., & Cohen, A. B.Nuclear magnetic resonance imaging technology: A clinical, industrial, and policy analysis (Health Technology Case Study #27), OTA-HCS-27. Washington, DC: U.S. Congress, Office of Technology Assessment, 1984.Google Scholar
43.Strich, G., Hagan, P. L., Gerber, K. H. et al. , Tissue distribution and magnetic resonance spin lattice relaxation effects of gadolinium-DPTA. Radiology, 1985, 154, 723–26.CrossRefGoogle Scholar
44.Taveras, J. M.Nuclear magnetic resonance terminology. American Journal of Radiology, 1983, 139, 1352–53.Google Scholar
45.Wedeen, V. J., Rosen, B. R., Chesler, D. et al. , MR velocity imaging by phase display. Journal of Computer Assisted Tomography, 1985, 9, 530–36.Google Scholar
46.White, R. M.Opportunities in magnetic materials. Science, 1985, 229, 1115.CrossRefGoogle ScholarPubMed